13F-HR filed by Octagon Capital Advisors LP
Octagon Capital Advisors LP filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-14, with 42 holding rows worth $642,901,677.
- Accession
- 0001839435-24-000008
- Filer
- CIK 1839435
- Filed
- 2024-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A holdings report, 42 entries on the cover page, a total value of $642,901,677 stated on the cover page (in dollars after the unit check, H1), rows summing to $642,901,677 with VALUE read as dollars as filed, 13F file number 028-20958. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 3,006,980 | $86,721,303 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 1,835,200 | $52,798,704 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 1,198,000 | $52,580,220 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 1,746,667 | $47,823,742 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 1,976,387 | $46,445,095 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 2,012,052 | $32,172,711 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 436,820 | $31,887,860 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 12,171,513 | $27,872,765 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 1,115,000 | $23,002,450 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 2,425,000 | $21,097,500 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 870,000 | $19,792,500 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 1,422,224 | $18,986,690 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 250,000 | $18,250,000 | dollars as filed | call |
| MIND MEDICINE MINDMED INC | 60255C885 | COM NEW | 3,018,000 | $17,172,420 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,305,000 | $14,094,000 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 552,000 | $14,053,920 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 620,470 | $11,491,104 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 262,726 | $9,437,118 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 4,572,222 | $9,190,166 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 9,187,883 | $9,062,928 | dollars as filed | |
| ALLOVIR INC | 019818103 | COM | 11,202,000 | $9,056,817 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 1,093,503 | $8,737,089 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 130,000 | $7,480,200 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 600,000 | $7,266,000 | dollars as filed | |
| REGULUS THERAPEUTICS INC | 75915K309 | COM | 4,263,701 | $6,694,011 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 2,391,114 | $5,212,629 | dollars as filed | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 2,576,200 | $4,972,066 | dollars as filed | |
| CYBIN INC | 23256X407 | COM NEW | 489,596 | $4,352,508 | dollars as filed | |
| RENEO PHARMACEUTICALS INC | 75974E103 | COM | 2,250,000 | $3,825,000 | dollars as filed | |
| UNICYCIVE THERAPEUTICS INC | 90466Y103 | CMN | 8,559,000 | $3,491,216 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 376,117 | $3,215,800 | dollars as filed | |
| HELIX ACQUISITION CORP II | G4444H101 | CL A ORD SHS | 250,000 | $2,612,475 | dollars as filed | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 594,000 | $2,583,900 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 400,000 | $2,368,000 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 992,000 | $1,874,880 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 666,825 | $1,140,271 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 465,440 | $972,770 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 312,336 | $715,249 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 176,000 | $638,880 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 15,000 | $629,400 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 292,000 | $586,920 | dollars as filed | |
| NKARTA INC | 65487U108 | COMMON STOCK | 120,000 | $542,400 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001839435-24-000008 | this filing | 2024-11-14 | acceptance time not in the bulk data set |